Case 1:24-cv-00336-RGA Document 26 Filed 01/13/25 Page 1 of 2 PageID #: 190
`
`IN THE UNITED STATES DISTRICT COURT
`FOR THE DISTRICT OF DELAWARE
`
`MDL NO. 21-MD-3017 (RGA)
`
`C.A. No. 24-336 (RGA)
`
`)
`)
`)
`)
`)
`)
`)
`)
`)
`)
`)
`)
`)
`
`)))
`
`
`
`IN RE: XARELTO (RIVAROXABAN) ’310
`PATENT LITIGATION
`
`BAYER INTELLECTUAL PROPERTY GMBH,
`BAYER PHARMA AG, BAYER AG, and
`JANSSEN PHARMACEUTICALS, INC.,
`
`Plaintiffs,
`
`v.
`
`PRINSTON PHARMACEUTICAL, INC.,
`
`Defendant.
`
`STIPULATION AND ORDER OF DISMISSAL
`
`Pursuant to Rules 41(a)(l) and 41(c) of the Federal Rules of Civil Procedure, and subject
`
`to the order of this Court, Plaintiffs Bayer Intellectual Property GmbH, Bayer Pharma AG, Bayer
`
`AG, and Janssen Pharmaceuticals, Inc. (collectively, “Plaintiffs”) and Defendant Prinston
`
`Pharmaceutical, Inc. (“Prinston”), hereby stipulate and agree that:
`
`Counts I and II of Plaintiffs’ Complaint against Prinston, asserting infringement of U.S.
`
`Patent No. 9,539,218 (“the ’218 patent”) based on Prinston’s Abbreviated New Drug Application
`
`(“ANDA”) No. 208549 for rivaroxaban tablets 10 mg, 15 mg, and 20 mg, including all claims and
`
`defenses asserted by Plaintiffs against Prinston and all claims and defenses asserted by Prinston
`
`against Plaintiffs in connection with Counts I and II and/or the ’218 patent, are hereby dismissed
`
`with prejudice.
`
`

`

`Case 1:24-cv-00336-RGA Document 26 Filed 01/13/25 Page 2 of 2 PageID #: 191
`
`All parties shall bear their own costs, disbursements and attorneys’ fees with respect to the
`
`’218 patent.
`
`Nothing in this stipulation and order impacts Counts III and IV of Plaintiffs’ Complaint
`
`against Prinston asserting infringement of U.S. Patent No. 10,828,310 (“the ’310 patent”) based
`
`on Prinston’s ANDA No. 208549 for rivaroxaban tablets 2.5 mg, and all claims and defenses
`
`asserted by Prinston against Plaintiffs on the ’310 patent, which remain pending in this action.
`
`MORRIS, NICHOLS, ARSHT & TUNNELL LLP
`
`HEYMAN ENERIO GATTUSO & HIRZEL, LLP
`
`/s/ Derek J. Fahnestock
`
`Rodger D. Smith II (#3778)
`Derek J. Fahnestock (#4705)
`1201 North Market Street
`P.O. Box 1347
`Wilmington, DE 19899
`(302) 658-9200
`rsmith@morrisnichols.com
`dfahnestock@morrisnichols.com
`
`/s/ Dominick T. Gattuso
`____________________________________
`Dominick T. Gattuso (#3630)
`300 Delaware Ave., Suite 200
`Wilmington, DE 19801
`Phone: (302) 472-7300
`dgattuso@hegh.law
`
`Attorney for Defendant Prinston
`Pharmaceutical, Inc.
`
`Attorneys for Plaintiffs Bayer Intellectual
`Property GmbH, Bayer Pharma AG, Bayer
`AG, and Janssen Pharmaceuticals, Inc.
`
`January 9, 2025
`
`13
`January
`SO ORDERED this ____ day of _________________, 2025.
`
`/s/ Richard G. Andrews
`UNITED STATES DISTRICT JUDGE
`
`2
`
`

Accessing this document will incur an additional charge of $.

After purchase, you can access this document again without charge.

Accept $ Charge

This document could not be displayed.

We could not find this document within its docket. Please go back to the docket page and check the link. If that does not work, go back to the docket and refresh it to pull the newest information.

Your account does not support viewing this document.

You need a Paid Account to view this document. Click here to change your account type.

Your account does not support viewing this document.

Set your membership status to view this document.

With a Docket Alarm membership, you'll get a whole lot more, including:

  • Up-to-date information for this case.
  • Email alerts whenever there is an update.
  • Full text search for other cases.
  • Get email alerts whenever a new case matches your search.

Become a Member

One Moment Please

The filing “” is large (MB) and is being downloaded.

Please refresh this page in a few minutes to see if the filing has been downloaded. The filing will also be emailed to you when the download completes.

Your document is on its way!

If you do not receive the document in five minutes, contact support at support@docketalarm.com.

Sealed Document

We are unable to display this document, it may be under a court ordered seal.

If you have proper credentials to access the file, you may proceed directly to the court's system using your government issued username and password.


Access Government Site

We are redirecting you
to a mobile optimized page.

We are unable to display this document.

PTO Denying Access

Refresh this Document
Go to the Docket